Premium Tech Insights for the Week of December 17...

Please do not reply to this message, as replies are routed to an unmonitored mailbox. You are receiving this email as a part of your subscription to Strategic Tech Investor. Your ability to alter your subscription information can be found at the bottom of this email. [Strategic Tech Investor] [Pay Attention to Line 40 ($2 Million Is Up for Grabs)]( It's the end of the year, and we've outdone ourselves again. So we're paying it forward - literally - by taking [$2 million out of our net income]( and sending that money straight to our readers. From our account to yours, I bet you won't receive a holiday greeting card quite like this from anyone else. [Details on how to claim this "holiday bonus..."]( --------------------------------------------------------------- December 23, 2018 Dear Strategic Tech Investor Reader, Winter is in full swing, along with the snow and ice storms, polar vortexes, frigid winds and short days. And while I'm a skiing enthusiast, and look forward to hitting the slopes, I'm not looking forward to the rising heating bills. At $4.60 per million British thermal units, natural gas, which is used to heat about half of all U.S. households, is at its highest price point in more than four years. If the cold temperatures many Americans are facing now continue into the New Year, we could wind up paying about 5% more in gas heating costs this winter. The U.S. Energy Information Administration (EIA) anticipates that if the weather is 10% colder this season, folks relying on heating oil could see their costs rise by as much as 33%. That amounts to an extra $585 in energy costs over the next few months. But here's the thing. Ultimately, those steep electricity bills we've come to expect this time of year are heading into extinction. And there's one tiny company that's behind this revolutionary electricity trend. In fact, the cost of solar went from $76 down to just $2.42 - a 99.97% fall - thanks largely to this firm's efforts. And my colleague, Money Moring's Global Energy Strategist, Dr. Kent Moors, has done the deep research on this firm. He's got nearly four decades of experience in the energy world, has consulted for 27 governments and traveled to 80 countries around the world during his career. [Access the information he's gathered on this company here](. Meanwhile, I've been unveiling tons more tech, cannabis and crypto profit opportunities in my premium services: [Nova-X Report]( and [Radical Technology Profits](. To check out what we've been looking at this week, just click on the links below. [The High-Tech Growth Stars to Watch in 2019]( We're heading toward the final stretch of one of the most challenging quarters for the market in many years. In times like this, it's easy to lose sight of the fact that the economy and tech sector spending continue to grow at a very solid rate. And in the Nova-X Report portfolio, you'll find some of the fastest-growing firms in all of tech. Once the market finds its footing, such firms are poised to renew their market leadership in 2019. [Take a look](... [Why I Think New York State Is Next]( During a morning speech where he outlined his 2019 priorities, New York Governor Andrew Cuomo said, "Let's legalize the adult use of recreational marijuana, once and for all." And that certainly wasn't easy for him, as he was calling marijuana "a gateway drug" as recently as a year ago. Thanks to its more than nearly 20 million residents - many of them potential customers - New York going fully legal will be quite the catalyst for the still young legal cannabis industry. [Here's how to play this huge move](... [This "Green Zone" Play Has a Savvy CEO at the Helm]( I had heard great things about the CEO of a cannabis pharma firm I've had my eye on. And I can say that after chatting with him earlier this month, he more than lived up to his reputation. You see, this CEO is the rare MD who also has his MBA. To round that out, he also has a master's degrees in both Pharmacology and Public Health from Harvard University. Now, he's focusing all of his energies on making his firm a major success. [Here's how](. [This Innovative New Partnership Is Hitting Back at Cancer]( As the fight against cancer rages on, a partnership has been struck up between two small-cap biotech firms that may finally have cancer cells backing down. These companies have created a tech that will target the BRCA gene, which - when present - brings an elevated chance of breast cancer. It uses the gene, and other DNA tests, to dictate the best treatment plan for the patient's body. You can learn more about this testing, and others like it, by [clicking here](. If you [Nova-X Report]( and [Radical Technology Profits]( members haven't caught up on my critical alerts, then take a look. For those of you who aren't yet members, all you need to do is click on the research service or alert that interests you. Then we'll show you how to gain immediate access to that service. Soon after, you'll start getting every single alert, special report, and newsletter the moment they're ready. Of course, there are many more benefits of becoming a member - so I hope you'll check these out. I'll be back next week with more. Cheers and good investing, Michael A. Robinson --------------------------------------------------------------- [Facebook]( [Twitter]( [More...]( mailto:?subject=Michael%20Robinson's%20Strategic%20Tech%20Investor&body=Check%20out%20http%3A%2F%2Fwww.strategictechinvestor.com%2F You are receiving this e-mail at, {EMAIL}, as a part of your free subscription to Strategic Tech Investor. Remove your email from this list: [Unsubscribe]( [Manage Your Email Preferences]( To cancel by mail or for any other subscription issues, write us at: Strategic Tech Investor | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201 North America: 888.384.8339; International: 443.353.4519; Fax: 410.622.3050 [Contact Customer Service]( Website: [( © 2018 Strategic Tech Investor All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Strategic Tech Investor. 1125 N Charles Street, Baltimore MD 21201.